160 related articles for article (PubMed ID: 1382595)
1. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
[TBL] [Abstract][Full Text] [Related]
2. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.
Auger KR; Carpenter CL; Shoelson SE; Piwnica-Worms H; Cantley LC
J Biol Chem; 1992 Mar; 267(8):5408-15. PubMed ID: 1372000
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.
Piccione E; Case RD; Domchek SM; Hu P; Chaudhuri M; Backer JM; Schlessinger J; Shoelson SE
Biochemistry; 1993 Apr; 32(13):3197-202. PubMed ID: 8384875
[TBL] [Abstract][Full Text] [Related]
4. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
5. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes.
Roche S; Dhand R; Waterfield MD; Courtneidge SA
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847
[TBL] [Abstract][Full Text] [Related]
6. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins.
Rameh LE; Chen CS; Cantley LC
Cell; 1995 Dec; 83(5):821-30. PubMed ID: 8521499
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.
Bjorge JD; Bellagamba C; Cheng HC; Tanaka A; Wang JH; Fujita DJ
J Biol Chem; 1995 Oct; 270(41):24222-8. PubMed ID: 7592628
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.
Otsu M; Hiles I; Gout I; Fry MJ; Ruiz-Larrea F; Panayotou G; Thompson A; Dhand R; Hsuan J; Totty N
Cell; 1991 Apr; 65(1):91-104. PubMed ID: 1707345
[TBL] [Abstract][Full Text] [Related]
10. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation.
Shoelson SE; Sivaraja M; Williams KP; Hu P; Schlessinger J; Weiss MA
EMBO J; 1993 Feb; 12(2):795-802. PubMed ID: 8382612
[TBL] [Abstract][Full Text] [Related]
11. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
12. Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.
Gilmer T; Rodriguez M; Jordan S; Crosby R; Alligood K; Green M; Kimery M; Wagner C; Kinder D; Charifson P
J Biol Chem; 1994 Dec; 269(50):31711-9. PubMed ID: 7527393
[TBL] [Abstract][Full Text] [Related]
13. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
Roussel RR; Brodeur SR; Shalloway D; Laudano AP
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A.
Glenn GM; Eckhart W
J Virol; 1995 Jun; 69(6):3729-36. PubMed ID: 7538175
[TBL] [Abstract][Full Text] [Related]
15. Association between src-kinases and the polyoma virus oncogene middle T-antigen requires PP2A and a specific sequence motif.
Glover HR; Brewster CE; Dilworth SM
Oncogene; 1999 Jul; 18(30):4364-70. PubMed ID: 10439044
[TBL] [Abstract][Full Text] [Related]
16. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.
Felder S; Zhou M; Hu P; Ureña J; Ullrich A; Chaudhuri M; White M; Shoelson SE; Schlessinger J
Mol Cell Biol; 1993 Mar; 13(3):1449-55. PubMed ID: 7680095
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.
Talmage DA; Freund R; Young AT; Dahl J; Dawe CJ; Benjamin TL
Cell; 1989 Oct; 59(1):55-65. PubMed ID: 2551507
[TBL] [Abstract][Full Text] [Related]
19. A photoaffinity scan maps regions of the p85 SH2 domain involved in phosphoprotein binding.
Williams KP; Shoelson SE
J Biol Chem; 1993 Mar; 268(8):5361-4. PubMed ID: 7680644
[TBL] [Abstract][Full Text] [Related]
20. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
